Menu
Search
|

Menu

Close
X

VBI Vaccines Inc VBIV.OQ (NASDAQ Stock Exchange Capital Market)

1.79 USD
-0.03 (-1.65%)
As of Nov 16
chart
Previous Close 1.82
Open 1.84
Volume 55,250
3m Avg Volume 49,520
Today’s High 1.98
Today’s Low 1.75
52 Week High 5.10
52 Week Low 1.64
Shares Outstanding (mil) 40.23
Market Capitalization (mil) 156.09
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.60 Mean rating from 5 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
1
FY16
1
FY15
0
EPS (USD)
FY18
-0.451
FY17
-0.889
FY16
-0.702
FY15
-12.126
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.59
Price to Sales (TTM)
vs sector
175.58
5.69
Price to Book (MRQ)
vs sector
2.25
5.11
Price to Cash Flow (TTM)
vs sector
--
23.52
Total Debt to Equity (MRQ)
vs sector
18.08
15.71
LT Debt to Equity (MRQ)
vs sector
17.51
11.53
Return on Investment (TTM)
vs sector
-38.92
15.05
Return on Equity (TTM)
vs sector
-42.80
16.62

EXECUTIVE LEADERSHIP

Curtis Lockshin
Chief Executive Officer, Director, Since 2015
Salary: --
Bonus: --
Christopher McNulty
Chief Financial Officer and Head of Business Development, Since 2018
Salary: --
Bonus: --
Athena Kartsaklis
Senior Vice President - Finance, Principal Accounting Officer, Chief Compliance Officer, Controller, Since 2018
Salary: --
Bonus: --
Shayla Forster
Corporate Secretary, Since 2015
Salary: --
Bonus: --
Dmitry Genkin
Director, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

222 3rd St Ste 2241
CAMBRIDGE   MA   02142-1259

Phone: +1617.8303031

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

SPONSORED STORIES